Boothbay Fund Management’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.5K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.22M | Sell |
|
|||||
|
2024
Q3 | $1.56M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $869K | Hold |
|
|||||
|
2021
Q4 | $2.04M | Sell |
|
|||||
|
2021
Q3 | $2.63M | Sell |
|
|||||
|
2021
Q2 | $4.04M | Hold |
|
|||||
|
2021
Q1 | $3.73M | Buy |
|
|||||
|
2020
Q4 | $3.06M | Hold |
|
|||||
|
2020
Q3 | $2.64M | Sell |
|
|||||
|
2020
Q2 | $3.09M | Buy |
|
|||||
|
2020
Q1 | $2.27M | Buy |
|
|||||
|
2019
Q4 | $2.62M | Buy |
|
|||||
|
2019
Q3 | $1.39M | Buy |
|
|||||
|
2019
Q2 | $1.84M | Hold |
|
|||||
|
2019
Q1 | $1.97M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $114K | Buy |
|
|||||
|
2018
Q1 | $94K | Buy |
|
|||||
|
2017
Q4 | $54K | Buy |
|